Such as ADT treatment induces the up-regulated expression of Nuclear receptor coactivator 2(NCoA2), which could activate the PI3K signaling pathway to promote prostate cancer metastasis and CRPC (4). This evidence concerns the gene NCOA2 and prostate carcinoma.